Documentos de Sharma V.K. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área temáticas: "Medicina y salud"

Subtipo de publicación

Conference Object(1)

Publisher

International Journal of Stroke(1)

JAMA Neurology(1)

Área temáticas

Enfermedades(2)

Ginecología, obstetricia, pediatría, geriatría(2)

Contabilidad(1)

Farmacología y terapéutica(1)

Área de conocimiento

Medicina interna(3)

Año de Publicación

Origen

Palabras Claves

Brain Infarction(1)

Clinical trial(1)

Hypertension(1)

Tissue plasminogen activator(1)

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Abstract: Background: Randomized controlled trials provide high-level evidence, but the necessity to include s

Palabras claves:

acute ischemic stroke, Alteplase, Clinical trial, health outcomes, thrombolysis

Arima H., Bath P.M.W., Bray B.D., Broderick J.P., Chalmers J., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Paley L., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Rudd A.G., S Anderson C., Sharma V.K., Sprigg N., Wang J.G., Wang X., Woodward M.

Low-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)

Conference Object

Abstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior a

Palabras claves:

aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activator

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.

Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial

Abstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the st

Palabras claves:

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.